A Clinical Perspective of Canagliflozin in the Management of Type 2 Diabetes Mellitus

OBJECTIVE: To assess the real-world efficacy and safety of the first sodium-glucose cotransporter-2 inhibitor, canagliflozin, in the treatment of patients with type 2 diabetes mellitus (T2DM). METHODS: This observational study assessed the efficacy and tolerability of canagliflozin in T2DM patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Nardolillo, AnneMarie, Kane, Michael P, Busch, Robert S, Watsky, Jay, Hamilton, Robert A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179440/
https://www.ncbi.nlm.nih.gov/pubmed/25288892
http://dx.doi.org/10.4137/CMED.S18182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179440/
https://www.ncbi.nlm.nih.gov/pubmed/25288892
http://dx.doi.org/10.4137/CMED.S18182

Ejemplares similares